Now we’ve dispensed with the nonsense “gay gene” trope, let’s interrogate the way we talk about genetics and traits full stop
By Philip Ball,
Prospect
| 09. 04. 2019
Some people once felt that the reason to look for a “gay gene” was so that it could be eliminated. Under the headline “Abortion hope after ‘gay genes’,” in 1993 the Daily Mail wrote “Isolation of the genes [causing homosexuality] means it could soon be possible to predict whether a baby will be gay and give the mother the option of an abortion.”
Revisiting that reporting now it has been announced that there is no “gay gene” shows us how much has changed over less than three decades in public attitudes to homosexuality. Sadly, there has not been a comparable change in public attitudes to genes. Few would now take the abhorrent view that a genetic propensity to being gay would constitute good grounds for termination of a pregnancy, but probably many would have no problem believing that your genes could “make you gay” in the first place. This latest interrogation of genetic determinism illustrates how far we have still to go to shift the prevailing narrative about genes.
The new research, led by a team at the Broad...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Antonio Regalado, MIT Technology Review | 10.31.2025
A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the taboo technology.
The new company, called Preventive, is...
